Netarsudil Dimesylate

Category: Vision / Eye Health



Netarsudil Dimesylate Overview

Netarsudil (trade name Rhopressa) is a drug for the treatment of glaucoma. In the United States in 2017 the Food and Drug Administration approved a 0.02% ophthalmic solution for the lowering of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.[1]It targets the trabecular meshwork directly[1] References ^ "Aerie (AERI) Gets Early FDA Approval for Lead Drug Rhopressa". December 19, 2017..mw-parser-output cite.citation{font-style:inh...

Read more Netarsudil Dimesylate Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Netarsudil

Recent Netarsudil Dimesylate Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Netarsudil Dimesylate
  • Solution/drops: 0.02%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Netarsudil Dimesylate or a similar ingredient: (3 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 November 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA